Gleneagles Hospital Hong Kong’s Peritoneal Malignancy Treatment Centre has introduced new intraperitoneal chemotherapy procedures, including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC), to provide more effective treatment to patients with peritoneal cancer.
Dr Kenneth Tsang, Chief Executive Officer of Gleneagles Hospital Hong Kong, said, “In addition to our advanced radiotherapy facilities, we have also launched a centre dedicated to serving patients with peritoneal metastasis. Our experienced multidisciplinary medical team provides patients with comprehensive diagnostic services and personalised treatments.” The Centre is the first of its kind in Hong Kong catering to patients with peritoneal metastasis. Medical studies have found HIPEC to effectively improve the survival rate of patients with ovarian cancer, gastric cancer or colorectal cancer. The innovative PIPAC treatment is also known to relieve symptoms of peritoneal metastasis and reduce the side effects of chemotherapy, which helps improve the patient’s quality of life.
Related Stories
IHH Healthcare Strengthens India Presence with Integrated Platform and Innovation Push
IHH Healthcare is accelerating its expansion in India, as rising healthcare demand drives the Group to scale its operations through integration, capacity growth and innovation-led initiatives.
IHH Healthcare calls for urgent shift from climate awareness to action at Sustainability Week Asia
At the 6th annual Economist Impact Sustainability Week Asia, IHH Healthcare’s Group Chief Sustainability Officer Yasemin Tecmen Stubbe underscored the growing urgency for organisations to embed climate resilience into day-to-day operations, rather than treating it as a future concern.
Parkway Shanghai Hospital Inaugurates Pan Vascular Centre
The new multidisciplinary hub integrates six specialties to deliver full-cycle care for vascular diseases, reinforcing healthcare innovation in China.
Gleneagles Hospital Hong Kong Participates in Fourth Red Cross City Challenge
Driven by IHH’s aspiration to “Care. For Good.”, Gleneagles Hospital Hong Kong continues its commitment to empower communities by continuously supporting humanitarian causes.
Fortis Healthcare Hosts 1st Annual Neuro-conclave Mumbai 2026
Fortis Healthcare marked the successful conclusion of the 1st Annual Neuro-conclave Mumbai 2026, held on 21 and 22 March, showcasing the strength and integration of its neuroscience team.
IHH Malaysia Supports 10KM Category at Penang Bridge International Marathon
IHH Malaysia is the 10KM title sponsor for the upcoming Penang Bridge International Marathon 2026 (PBIM), encouraging individuals of all fitness levels to embrace a more active lifestyle.
